JNTU

JNTU B.Pharmacy III PHARMACEUTICAL QUALITY ASSURANCE Previous Question Paper (August - 2022 - R17)

B.Pharmacy | III | II | R17 | August - 2022

Answer PaperPaper Code: 246AEMaximum Marks: 75Time: 3 Hours

Answer any five questions

All questions carry equal marks

Main

1

Explain in detail about process of ISO 9000 registration for a pharmaceutical industry.

15 marks

Answer

The process of ISO 9000 registration in a pharmaceutical industry is a formal, systematic procedure involving the implementation of a Quality Management System (QMS) followed by an external audit by an accredited registrar. The process follows these key stages:

  1. Gap Analysis: The organization evaluates its existing quality systems against ISO 9001 requirements to identify deficiencies.
  2. Quality Policy and Objectives: Management defines the quality policy and sets measurable objectives aligned with regulatory requirements (e.g., cGMP).
  3. Documentation Development: This includes creating the Quality Manual, Standard Operating Procedures (SOPs), work instructions, and quality records necessary to demonstrate compliance.
  4. Implementation and Training: All personnel are trained on the new QMS processes. The system is then implemented across all departments, and records are generated to provide evidence of compliance.
  5. Internal Audit: The organization conducts a thorough internal audit to verify that the QMS is functioning as intended and to identify areas for corrective action before the external audit.
  6. Management Review: Top management reviews the QMS performance, audit results, and feedback to ensure the system remains suitable and effective.
  7. Selection of Registrar: A third-party accredited certification body is selected to conduct the formal assessment.
  8. Stage 1 Audit (Document Review): The registrar reviews the documentation to ensure it meets the ISO 9001 standard requirements.
  9. Stage 2 Audit (On-site Assessment): The registrar performs an on-site audit to verify that the actual practices match the documented procedures and that the system is fully operational.
  10. Certification and Surveillance: If the audit is successful, the registrar issues the ISO 9001 certificate. The organization then undergoes periodic surveillance audits (usually annually) to ensure continued compliance and commitment to quality improvement.

Successful registration demonstrates to stakeholders that the pharmaceutical facility maintains a consistent, high-quality manufacturing process that meets both customer expectations and international standards.

2

Discuss in detail about process of NABL accreditation for a testing laboratory.

15 marks

Answer

NABL (National Accreditation Board for Testing and Calibration Laboratories) accreditation is a formal recognition of the technical competence of a testing laboratory based on the ISO/IEC 17025 standard. The accreditation process is a structured, multi-stage procedure designed to ensure quality, accuracy, and reliability of test results.

The process follows these key steps:

  1. Application Submission: The laboratory must submit a formal application to NABL in the prescribed format, including the Quality Manual, standard operating procedures, and the scope of accreditation (the specific tests for which accreditation is sought).
  2. Document Review: NABL conducts a thorough review of the submitted Quality Manual and supporting documentation to ensure they comply with the requirements of ISO/IEC 17025. If deficiencies are found, the laboratory is required to take corrective actions.
  3. Pre-assessment: An NABL-appointed lead assessor visits the laboratory to evaluate its preparedness. This stage identifies any gaps in the laboratory's quality system or technical operations before the final assessment.
  4. On-site Assessment: A team of technical assessors conducts a comprehensive on-site audit. They evaluate the laboratory's infrastructure, equipment calibration, personnel competence, method validation, proficiency testing, and adherence to the documented quality management system.
  5. Non-Conformance Reporting: During the assessment, any deviations from the standard are documented as Non-Conformances (NCs). The laboratory must provide a root cause analysis and implement corrective actions within a stipulated timeframe.
  6. Review and Approval: The assessment report, along with the laboratory's corrective actions, is reviewed by the NABL Accreditation Committee. If the committee is satisfied that the laboratory meets all criteria, it recommends the grant of accreditation.
  7. Grant of Accreditation: NABL issues the accreditation certificate, which specifies the scope of testing and the validity period (usually three years).

Post-accreditation, the laboratory is subject to periodic surveillance audits to ensure continued compliance with the quality standards. Proficiency testing and inter-laboratory comparisons are mandatory requirements to maintain the accreditation status.

3

Discuss in detail about maintenance of stores for raw materials for a pharmaceutical facility.

15 marks

Answer

Sign in to view the complete answer paper.

4

Discuss in detail about design, construction and plant layout for sterile pharmaceutical facility.

15 marks

Answer

Sign in to view the complete answer paper.

5

Discuss in detail about key elements of good laboratory practices with relevant examples.

15 marks

Answer

Sign in to view the complete answer paper.

6

Explain in detail about disqualification of testing facilities with the help of any five relevant case studies.

15 marks

Answer

Sign in to view the complete answer paper.

7

Discuss in detail about complaints and evaluation of complaints and its significance for the pharmaceutical business.

15 marks

Answer

Sign in to view the complete answer paper.

8

Design a protocol for analytical method validation as per ICH guidelines.

15 marks

Answer

Sign in to view the complete answer paper.

About this paper

This page contains the solved question paper with answers of PHARMACEUTICAL QUALITY ASSURANCE from JNTU for B.Pharmacy III II, August - 2022, R17.

For the question paper without answers, switch to the Question Paper tab.

Other papers in PHARMACEUTICAL QUALITY ASSURANCE

Loading Question Papers

Fetching data from database...